• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类血小板中利钠肽C受体的年龄调节可能性。

Possibility of age regulation of the natriuretic peptide C-receptor in human platelets.

作者信息

Giannessi D, Andreassi M G, Del Ry S, Clerico A, Colombo M G, Dini N

机构信息

CNR Institute of Clinical Physiology, Pisa, Italy.

出版信息

J Endocrinol Invest. 2001 Jan;24(1):8-16. doi: 10.1007/BF03343802.

DOI:10.1007/BF03343802
PMID:11227736
Abstract

Natriuretic peptide binding sites on platelets have been hypothesized to act as clearance receptors; however, there is no clear definition of the function of this receptor. The aim of the study was: 1) to characterize natriuretic peptide receptors in human platelets by original competition study; 2) to evaluate a possible age modulation of these binding sites, since a delayed clearance of ANP in the elderly has been observed. The binding of 125I-ANP to intact platelets was completely inhibited by h-ANP, h-BNP, h-CNP and c-ANP, the selective ligand of the clearance receptor. IC50 values were 0.089+/-0.029, 0.703+/-0.104 and 1.19+/-0.13, 3.84+/-0.04 nmol/l, mean+/-SE, respectively (p<0.001 for IC50 value of h-ANP compared to the other natriuretic peptides). This observation on the receptor selectivity of natriuretic peptides in human platelets provides new evidence for the presence of the clearance receptor on platelets. In control subjects the Kd was 34.6+/-4.0 pmol/l and Bmax 13.6+/-0.92 fmol/10(9) platelets (mean+/-SE), (no.=46, mean age 41.7+/-2.1 years). Bmax was significantly reduced in older subjects (no.=25, mean age 53.2+/-1.5 years) with respect to the younger group (no.=21, mean age 28.0+/-0.87 years): 11.4+/-1.1 vs 16.1+/-1.4 fmol/10(9) cells, p=0.0096, respectively; moreover, a significant inverse relationship between Bmax and the subject's age was observed. This observation suggests a possible reduction of the natriuretic peptide clearance with aging, associated to a significant increase of plasma levels of natriuretic peptides.

摘要

血小板上的利钠肽结合位点被推测可作为清除受体;然而,该受体的功能尚无明确界定。本研究的目的是:1)通过原创性竞争研究来表征人血小板中的利钠肽受体;2)评估这些结合位点可能存在的年龄调节情况,因为已观察到老年人中ANP清除延迟。125I-ANP与完整血小板的结合被h-ANP、h-BNP、h-CNP以及清除受体的选择性配体c-ANP完全抑制。IC50值分别为0.089±0.029、0.703±0.104、1.19±0.13、3.84±0.04 nmol/l,均值±标准误(与其他利钠肽相比,h-ANP的IC50值p<0.001)。这一关于人血小板中利钠肽受体选择性的观察结果为血小板上存在清除受体提供了新证据。在对照组受试者中,Kd为34.6±4.0 pmol/l,Bmax为13.6±0.92 fmol/10⁹血小板(均值±标准误)(n=46,平均年龄41.7±2.1岁)。与较年轻组(n=21,平均年龄28.0±0.87岁)相比,老年受试者(n=25,平均年龄53.2±1.5岁)的Bmax显著降低:分别为11.4±1.1与16.1±1.4 fmol/10⁹细胞,p=0.0096;此外,观察到Bmax与受试者年龄之间存在显著的负相关关系。这一观察结果表明,随着年龄增长,利钠肽清除可能减少,这与利钠肽血浆水平显著升高相关。

相似文献

1
Possibility of age regulation of the natriuretic peptide C-receptor in human platelets.人类血小板中利钠肽C受体的年龄调节可能性。
J Endocrinol Invest. 2001 Jan;24(1):8-16. doi: 10.1007/BF03343802.
2
Localisation and characteristics of natriuretic peptide receptors in the gills of the Atlantic hagfish Myxine glutinosa (Agnatha).大西洋盲鳗(Myxine glutinosa,无颌纲)鳃中利钠肽受体的定位与特征
J Exp Biol. 1995 Jan;198(Pt 1):117-26. doi: 10.1242/jeb.198.1.117.
3
Characterization of human platelet receptors for atrial natriuretic peptide: evidence for clearance receptors.人心房钠尿肽血小板受体的特性:清除受体的证据
Cell Mol Biol (Noisy-le-grand). 1996 Dec;42(8):1173-9.
4
[The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].[急性心肌梗死患者心房利钠肽和脑利钠肽临床预后重要性的研究]
Pol Merkur Lekarski. 2002 Jan;12(67):15-9.
5
Type B and type C natriuretic peptide receptors modulate intraocular pressure in the rabbit eye.
Eur J Pharmacol. 1999 Jan 8;364(2-3):107-13. doi: 10.1016/s0014-2999(98)00828-0.
6
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.利钠肽家族、心房利钠肽、脑利钠肽和C型利钠肽的受体选择性。
Endocrinology. 1992 Jan;130(1):229-39. doi: 10.1210/endo.130.1.1309330.
7
Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.心房利钠肽(ANP)通过ANP(A)受体抑制其自身分泌:实验性高血压中的效应改变。
Endocrinology. 1997 May;138(5):1893-902. doi: 10.1210/endo.138.5.5120.
8
Vascular effects of natriuretic peptides in healthy men.利钠肽对健康男性的血管作用
J Cardiovasc Pharmacol Ther. 2004 Dec;9(4):263-70. doi: 10.1177/107424840400900406.
9
Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure.
Clin Sci (Lond). 1988 Feb;74(2):213-8. doi: 10.1042/cs0740213.
10
Solubilization and molecular characterization of the atrial natriuretic peptide (ANP) receptor in human platelets: comparison with ANP receptors in rat tissues.人血小板中心房钠尿肽(ANP)受体的增溶与分子特性:与大鼠组织中ANP受体的比较。
J Clin Endocrinol Metab. 1991 Feb;72(2):484-91. doi: 10.1210/jcem-72-2-484.

引用本文的文献

1
The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients.脑钠肽在老年心力衰竭评估中的应用
Diagnostics (Basel). 2023 Apr 23;13(9):1512. doi: 10.3390/diagnostics13091512.
2
Tayside Screening For Cardiac Events (TASCFORCE) study: a prospective cardiovascular risk screening study.泰赛德心血管事件筛查(TASCFORCE)研究:一项前瞻性心血管风险筛查研究。
BMJ Open. 2022 Oct 21;12(10):e063594. doi: 10.1136/bmjopen-2022-063594.
3
Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure-A Comparative Review.

本文引用的文献

1
Molecular biology of the natriuretic peptides.利钠肽的分子生物学。
Trends Cardiovasc Med. 1994 Jul-Aug;4(4):159-65. doi: 10.1016/1050-1738(94)90052-3.
2
The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.利钠肽清除受体在局部调节利钠肽系统的生理效应。
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7403-8. doi: 10.1073/pnas.96.13.7403.
3
Measurement and significance of circulating natriuretic peptides in cardiovascular disease.循环利钠肽在心血管疾病中的测定及其意义
心房利钠肽作为小儿心力衰竭生物标志物的潜力与局限性——一项比较性综述
Front Pediatr. 2019 Jan 29;6:420. doi: 10.3389/fped.2018.00420. eCollection 2018.
4
Plasma levels of natriuretic peptides and year-by-year blood pressure variability: a population-based study.利钠肽的血浆水平与逐年血压变异性:一项基于人群的研究。
J Hum Hypertens. 2017 Aug;31(8):525-529. doi: 10.1038/jhh.2017.14. Epub 2017 Mar 2.
5
Plasma levels of natriuretic peptides and development of chronic kidney disease.利钠肽的血浆水平与慢性肾脏病的发生发展
BMC Nephrol. 2015 Oct 24;16:171. doi: 10.1186/s12882-015-0163-9.
6
Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.N 末端脑利钠肽前体与高血压性心脏病舒张功能的关系。
Am J Hypertens. 2013 Oct;26(10):1234-41. doi: 10.1093/ajh/hpt098. Epub 2013 Jun 22.
7
Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study).健康个体中 N-末端 pro-B 型利钠肽的参考范围(来自弗雷明汉心脏研究)。
Am J Cardiol. 2011 Nov 1;108(9):1341-5. doi: 10.1016/j.amjcard.2011.06.057. Epub 2011 Aug 23.
8
Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.N末端脑钠肽前体在老年急性心肌梗死患者中的预后价值:前瞻性观察研究
BMJ. 2009 May 6;338:b1605. doi: 10.1136/bmj.b1605.
9
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.普通人群中的氨基末端前B型利钠肽和B型利钠肽:左心室功能障碍的决定因素及检测
J Am Coll Cardiol. 2006 Jan 17;47(2):345-53. doi: 10.1016/j.jacc.2005.09.025. Epub 2006 Jan 4.
10
Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus.英格兰东北部孕妇膳食碘摄入不足的患病率:对胎儿的影响。
Arch Dis Child Fetal Neonatal Ed. 2004 Sep;89(5):F436-9. doi: 10.1136/adc.2003.029306.
Clin Sci (Lond). 1998 Nov;95(5):519-29. doi: 10.1042/cs0950519.
4
Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma.人血浆中利钠肽原N端片段的免疫放射分析
Clin Chem. 1998 May;44(5):1008-13.
5
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.利钠肽在基层医疗中评估可能患有新发心力衰竭患者的价值。
Lancet. 1997 Nov 8;350(9088):1349-53. doi: 10.1016/S0140-6736(97)06031-5.
6
Characterization of human platelet receptors for atrial natriuretic peptide: evidence for clearance receptors.人心房钠尿肽血小板受体的特性:清除受体的证据
Cell Mol Biol (Noisy-le-grand). 1996 Dec;42(8):1173-9.
7
Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients.
J Psychiatr Res. 1996 May-Jun;30(3):169-84. doi: 10.1016/0022-3956(96)00019-2.
8
Effects of age on the role of atrial natriuretic factor in renal adaptation to physiologic variations of dietary salt intake.
J Am Soc Nephrol. 1996 Jul;7(7):1045-51. doi: 10.1681/ASN.V771045.
9
Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.人脑利钠肽对正常男性的肾脏、内分泌及血流动力学影响。
J Clin Endocrinol Metab. 1993 Jan;76(1):91-6. doi: 10.1210/jcem.76.1.8380606.
10
Differential regulation of ANF-R2 receptors coupled to adenylyl cyclase in cardiovascular tissues in hypertension.高血压患者心血管组织中与腺苷酸环化酶偶联的心房钠尿肽受体2(ANF-R2)的差异调节
Am J Hypertens. 1993 Jun;6(6 Pt 1):538-41. doi: 10.1093/ajh/6.6.538.